Published in Am J Trop Med Hyg on March 01, 2005
Plasmodium malariae and Plasmodium ovale--the "bashful" malaria parasites. Trends Parasitol (2007) 2.04
Comparison of real-time PCR and microscopy for malaria parasite detection in Malawian pregnant women. Malar J (2010) 1.94
Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant women. Malar J (2009) 1.87
Detection and clinical manifestation of placental malaria in southern Ghana. Malar J (2006) 1.52
Systematic review and meta-analysis: rapid diagnostic tests versus placental histology, microscopy and PCR for malaria in pregnant women. Malar J (2011) 1.32
Diagnostic comparison of malaria infection in peripheral blood, placental blood and placental biopsies in Cameroonian parturient women. Malar J (2009) 1.14
Malaria in pregnancy. Mediterr J Hematol Infect Dis (2013) 1.11
Diagnosis of gestational, congenital, and placental malaria in Colombia: comparison of the efficacy of microscopy, nested polymerase chain reaction, and histopathology. Am J Trop Med Hyg (2011) 1.09
High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria. PLoS One (2012) 1.09
Submicroscopic malaria infection during pregnancy and the impact of intermittent preventive treatment. Malar J (2014) 1.07
Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission. Am J Trop Med Hyg (2010) 1.06
Elevated levels of IL-10 and G-CSF associated with asymptomatic malaria in pregnant women. Infect Dis Obstet Gynecol (2010) 1.05
Diagnosing malaria in pregnancy: an update. Expert Rev Anti Infect Ther (2012) 1.01
Malaria risk factors in women on intermittent preventive treatment at delivery and their effects on pregnancy outcome in Sanaga-Maritime, Cameroon. PLoS One (2013) 1.00
Isolation and characterization of the MSP1 genes from Plasmodium malariae and Plasmodium ovale. Am J Trop Med Hyg (2010) 0.99
Malaria at parturition in Nigeria: current status and delivery outcome. Infect Dis Obstet Gynecol (2009) 0.98
Intermittent preventive treatment with sulfadoxine-pyrimethamine against malaria and anemia in pregnant women. Am J Trop Med Hyg (2011) 0.97
Prospective evaluation of artemether-lumefantrine for the treatment of non-falciparum and mixed-species malaria in Gabon. Malar J (2012) 0.93
Quantification of the burden and consequences of pregnancy-associated malaria in the Democratic Republic of the Congo. J Infect Dis (2011) 0.92
The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding site. PLoS One (2014) 0.92
Induction of strain-transcendent antibodies to placental-type isolates with VAR2CSA DBL3 or DBL5 recombinant proteins. Malar J (2011) 0.91
Imported submicroscopic malaria in Madrid. Malar J (2012) 0.90
Molecular detection of malaria at delivery reveals a high frequency of submicroscopic infections and associated placental damage in pregnant women from northwest Colombia. Am J Trop Med Hyg (2013) 0.90
Submicroscopic and multiple plasmodium falciparum infections in pregnant Sudanese women. N Am J Med Sci (2011) 0.90
Plasmodium falciparum population dynamics in a cohort of pregnant women in Senegal. Malar J (2010) 0.89
Malaria burden in pregnancy at mulago national referral hospital in kampala, Uganda. Malar Res Treat (2010) 0.84
Non-falciparum malaria infections in pregnant women in West Africa. Malar J (2016) 0.82
Malaria parasite detection increases during pregnancy in wild chimpanzees. Malar J (2014) 0.81
High burden of malaria infection in pregnant women in a rural district of Zambia: a cross-sectional study. Malar J (2015) 0.81
Prospects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites. Malar Res Treat (2012) 0.81
What is the burden of submicroscopic malaria in pregnancy in central India? Pathog Glob Health (2015) 0.78
Evaluation of oxidative stress and antioxidant status of pregnant women suffering from malaria in Cameroon. Indian J Clin Biochem (2009) 0.78
Prevalence of malaria in pregnancy in southern Laos: a cross-sectional survey. Malar J (2016) 0.77
Epidemiology and Risk Analysis of Malaria among Pregnant Women. Iran J Public Health (2012) 0.76
Cloning and Sequence Analysis of Recombinant Plasmodium vivax Merozoite Surface Protein 1 (PvMSP-142 kDa) In pTZ57R/T Vector. Iran J Parasitol (2015) 0.75
Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensities. BMC Med (2017) 0.75
Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis (2007) 4.35
Protection against a malaria challenge by sporozoite inoculation. N Engl J Med (2009) 4.03
Malaria in pregnancy: pathogenesis and immunity. Lancet Infect Dis (2007) 3.88
Two nonrecombining sympatric forms of the human malaria parasite Plasmodium ovale occur globally. J Infect Dis (2010) 3.21
On the cytoadhesion of Plasmodium vivax-infected erythrocytes. J Infect Dis (2010) 2.91
Spurious amplification of a Plasmodium vivax small-subunit RNA gene by use of primers currently used to detect P. knowlesi. J Clin Microbiol (2009) 2.85
On the diversity of malaria parasites in African apes and the origin of Plasmodium falciparum from Bonobos. PLoS Pathog (2010) 2.60
On the pathogenic role of brain-sequestered alphabeta CD8+ T cells in experimental cerebral malaria. J Immunol (2002) 2.40
Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrob Agents Chemother (2003) 2.26
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Lancet Infect Dis (2010) 2.24
A reliable ex vivo invasion assay of human reticulocytes by Plasmodium vivax. Blood (2011) 2.17
Practical PCR genotyping protocols for Plasmodium vivax using Pvcs and Pvmsp1. Malar J (2005) 2.15
Protective T cell immunity against malaria liver stage after vaccination with live sporozoites under chloroquine treatment. J Immunol (2004) 2.12
Effective and cheap removal of leukocytes and platelets from Plasmodium vivax infected blood. Malar J (2009) 2.08
The genetic diversity of Plasmodium vivax populations. Trends Parasitol (2003) 2.01
Plasmodium sporozoites trickle out of the injection site. Cell Microbiol (2007) 1.98
Validity and reliability of activity measures in African-American girls for GEMS. Med Sci Sports Exerc (2003) 1.86
Risk factors for placental malaria and its effect on pregnancy outcome in Yaounde, Cameroon. Am J Trop Med Hyg (2005) 1.84
Invasion of host cells by malaria parasites: a tale of two protein families. Mol Microbiol (2007) 1.79
A pre-emptive strike against malaria's stealthy hepatic forms. Nat Rev Drug Discov (2009) 1.77
Plasmodium falciparum msp1, msp2 and glurp allele frequency and diversity in sub-Saharan Africa. Malar J (2011) 1.66
Molecular characterization of dihydrofolate reductase in relation to antifolate resistance in Plasmodium vivax. Mol Biochem Parasitol (2002) 1.62
Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria. J Infect Dis (2003) 1.60
Towards an in vitro model of Plasmodium hypnozoites suitable for drug discovery. PLoS One (2011) 1.60
Multiplex assay for simultaneous measurement of antibodies to multiple Plasmodium falciparum antigens. Clin Vaccine Immunol (2006) 1.55
Malaria vectors and transmission dynamics in coastal south-western Cameroon. Malar J (2007) 1.54
Vaccination with live Plasmodium yoelii blood stage parasites under chloroquine cover induces cross-stage immunity against malaria liver stage. J Immunol (2008) 1.53
Molecular genotyping to distinguish between recrudescents and new infections in treatment trials of Plasmodium falciparum malaria conducted in Sub-Saharan Africa: adjustment of parasitological outcomes and assessment of genotyping effectiveness. Trop Med Int Health (2006) 1.50
A plant-derived morphinan as a novel lead compound active against malaria liver stages. PLoS Med (2006) 1.49
Environmental influence on the genetic basis of mosquito resistance to malaria parasites. Proc Biol Sci (2006) 1.48
Population structure analysis of Plasmodium vivax in areas of iran with different malaria endemicity. Am J Trop Med Hyg (2006) 1.46
Pathogenic T cells in cerebral malaria. Int J Parasitol (2006) 1.45
Rapid species diagnosis for invasive candidiasis using mass spectrometry. PLoS One (2010) 1.44
Sterile protection against malaria is independent of immune responses to the circumsporozoite protein. PLoS One (2007) 1.41
High deformability of Plasmodium vivax-infected red blood cells under microfluidic conditions. J Infect Dis (2009) 1.40
Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrob Agents Chemother (2005) 1.33
Considerations on the use of nucleic acid-based amplification for malaria parasite detection. Malar J (2011) 1.32
Physical activity self-report and accelerometry measures from the Girls health Enrichment Multi-site Studies. Prev Med (2004) 1.30
Chloroquine resistant vivax malaria in a pregnant woman on the western border of Thailand. Malar J (2011) 1.29
Plasmodium falciparum: PCR detection and genotyping of isolates from peripheral, placental, and cord blood of pregnant Malawian women and their infants. Trans R Soc Trop Med Hyg (2002) 1.28
Circumsporozoite protein gene diversity among temperate and tropical Plasmodium vivax isolates from Iran. Trop Med Int Health (2006) 1.27
MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole. Proteomics (2009) 1.26
Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Trans R Soc Trop Med Hyg (2002) 1.25
Are extensive T cell epitope polymorphisms in the Plasmodium falciparum circumsporozoite antigen, a leading sporozoite vaccine candidate, selected by immune pressure? J Immunol (2005) 1.22
Detection of Rickettsia africae in patients and ticks along the coastal region of Cameroon. Am J Trop Med Hyg (2004) 1.21
Severe malaria in Cameroonian children: correlation between plasma levels of three soluble inducible adhesion molecules and TNF-alpha. Acta Trop (2007) 1.20
Measurement characteristics of activity-related psychosocial measures in 8- to 10-year-old African-American girls in the Girls Health Enrichment Multisite Study (GEMS). Prev Med (2004) 1.19
Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection. PLoS Pathog (2008) 1.19
The evolutionary history of Plasmodium vivax as inferred from mitochondrial genomes: parasite genetic diversity in the Americas. Mol Biol Evol (2013) 1.18
Timing the origin of human malarias: the lemur puzzle. BMC Evol Biol (2011) 1.17
High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission. Infect Immun (2012) 1.15
Genetic complexity of Plasmodium falciparum gametocytes isolated from the peripheral blood of treated Gambian children. Am J Trop Med Hyg (2002) 1.15
Recombinant human IFN-alpha inhibits cerebral malaria and reduces parasite burden in mice. J Immunol (2007) 1.14
Multiple genotypes of the merozoite surface proteins 1 and 2 in Plasmodium falciparum infections in a hypoendemic area in Iran. Trop Med Int Health (2005) 1.14
Inhibitory effect of TNF-α on malaria pre-erythrocytic stage development: influence of host hepatocyte/parasite combinations. PLoS One (2011) 1.12
Genetic analysis of the dihydrofolate reductase-thymidylate synthase gene from geographically diverse isolates of Plasmodium malariae. Antimicrob Agents Chemother (2007) 1.10
Environmental factors affecting malaria parasite prevalence in rural Bolifamba, South West Cameroon. Afr J Health Sci (2007) 1.09
High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria. PLoS One (2012) 1.09
Malaria-associated cytokine changes in the placenta of women with pre-term deliveries in Yaounde, Cameroon. Am J Trop Med Hyg (2003) 1.07
Minimal role for the circumsporozoite protein in the induction of sterile immunity by vaccination with live rodent malaria sporozoites. Infect Immun (2010) 1.06
Molecular typing reveals substantial Plasmodium vivax infection in asymptomatic adults in a rural area of Cameroon. Malar J (2014) 1.06
Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission. Am J Trop Med Hyg (2010) 1.06
Transmission of mixed Plasmodium species and Plasmodium falciparum genotypes. Am J Trop Med Hyg (2003) 1.03
Performance of a histidine-rich protein 2 rapid diagnostic test, Paracheck Pf®, for detection of malaria infections in Ugandan pregnant women. Am J Trop Med Hyg (2012) 1.03
The Py235 proteins: glimpses into the versatility of a malaria multigene family. Microbes Infect (2004) 1.03
Congenital exposure to Plasmodium falciparum antigens: prevalence and antigenic specificity of in utero-produced antimalarial immunoglobulin M antibodies. Infect Immun (2003) 1.02
Artesunate-dapsone-proguanil treatment of falciparum malaria: genotypic determinants of therapeutic response. Trans R Soc Trop Med Hyg (2005) 1.02
A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites. PLoS One (2009) 1.01
Preparation and characterization of specific monoclonal antibodies for the detection of adult worm infections in onchocerciasis. Hybridoma (Larchmt) (2005) 1.01
Elevated levels of soluble TNF receptors 1 and 2 correlate with Plasmodium falciparum parasitemia in pregnant women: potential markers for malaria-associated inflammation. J Immunol (2010) 1.01
Fetal immune responses to Plasmodium falciparum antigens in a malaria-endemic region of Cameroon. J Immunol (2007) 1.00
Human leukocyte antigen class II alleles influence levels of antibodies to the Plasmodium falciparum asexual-stage apical membrane antigen 1 but not to merozoite surface antigen 2 and merozoite surface protein 1. Infect Immun (2004) 0.98
A new real-time PCR for the detection of Plasmodium ovale wallikeri. PLoS One (2012) 0.97
Transmission of Plasmodium vivax in south-western Uganda: report of three cases in pregnant women. PLoS One (2011) 0.97
Vaccination against malaria with live parasites. Expert Rev Vaccines (2006) 0.96
Cerebral malaria: in praise of epistemes. Trends Parasitol (2010) 0.96
Species-specific inhibition of cerebral malaria in mice coinfected with Plasmodium spp. Infect Immun (2005) 0.95
Resistance and susceptibility to filarial infection with Litomosoides sigmodontis are associated with early differences in parasite development and in localized immune reactions. Infect Immun (2003) 0.95
Dysregulation of angiopoietins is associated with placental malaria and low birth weight. PLoS One (2010) 0.94
Microsatellite genotyping of Plasmodium vivax infections and their relapses in pregnant and non-pregnant patients on the Thai-Myanmar border. Malar J (2013) 0.93
Hypericum lanceolatum (Hypericaceae) as a potential source of new anti-malarial agents: a bioassay-guided fractionation of the stem bark. Malar J (2011) 0.92
Human ex vivo studies on asexual Plasmodium vivax: the best way forward. Int J Parasitol (2012) 0.92
Increased early local immune responses and altered worm development in high-dose infections of mice susceptible to the filaria Litomosoides sigmodontis. Med Microbiol Immunol (2004) 0.91
The suitability of P. falciparum merozoite surface proteins 1 and 2 as genetic markers for in vivo drug trials in Yemen. PLoS One (2013) 0.90